Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00628771 · ClinicalTrials.gov registry record · Phase 4

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

A Phase 4 study of HIV Infections and Pregnancy, sponsored by Yale University.

Completed
Registry status
Phase 4
Development phase
1,233
Enrollment target
3
Study locations

NCT00628771 is a Phase 4 study of HIV Infections and Pregnancy that has completed, run by Yale University. The registered enrollment target is 1,233 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (178% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00628771, a Phase 4 study of HIV Infections and Pregnancy, has completed, sponsored by Yale University.

COMPLETED
Registry status
Phase 4
Development phase
1,233 participants
Enrollment target
3
Study locations

Study Summary

This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropolitan area.

Conditions Studied

HIV Infections Pregnancy Sexually Transmitted Diseases

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL CenteringPregnancy Plus (CP+)

Study Locations (3)

Connecticut

  • Yale University School of PUblic Health - New Haven

Massachusetts

  • Centering Healthcare Institute - Boston

New York

  • Clinical Directors Network - New York

Trial Details

FieldValue
Enrollment Target 1,233 participants
Start Date 2008-06
Est. Completion 2012-09
Phase Phase 4

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00628771

The ClinicalTrials.gov registry entry for NCT00628771 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 1,233 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (178% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT00628771 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT00628771 about?

NCT00628771 is a clinical study titled "Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women". This study will evaluate the effectiveness of CenteringPregnancy Plus, a group prenatal care treatment program with an HIV/sexually transmitted disease prevention component, in reducing health risk behaviors in pregnant teenagers seeking services at Community Health Centers in the New York metropoli...

What is the current status of trial NCT00628771?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,233 participants. The study started on 2008-06. Estimated completion is 2012-09.

What conditions does trial NCT00628771 study?

This clinical trial studies the following conditions: HIV Infections, Pregnancy, Sexually Transmitted Diseases.

What interventions are being tested in trial NCT00628771?

The interventions under investigation include: Usual care (BEHAVIORAL), CenteringPregnancy Plus (CP+) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00628771?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00628771 being conducted?

This trial has 3 study locations across Connecticut, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Pregnancy

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.